| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015857953 |
| P356 | DOI | 10.1038/SJ.ONC.1208564 |
| P698 | PubMed publication ID | 15782119 |
| P5875 | ResearchGate publication ID | 7953230 |
| P50 | author | Naoki Yamamoto | Q86902511 |
| P2093 | author name string | Shoji Yamaoka | |
| Toshiki Watanabe | |||
| Ryouichi Horie | |||
| Mizuho Nonaka | |||
| Kinji Itoh | |||
| P2860 | cites work | TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 |
| BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2 | Q27639845 | ||
| MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival | Q28190315 | ||
| NF-kappaB regulation in the immune system | Q28205043 | ||
| Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family | Q28208696 | ||
| Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity | Q28383134 | ||
| Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines | Q28565703 | ||
| Shaping the nuclear action of NF-kappaB | Q29614600 | ||
| Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation | Q29617419 | ||
| TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. | Q31148506 | ||
| OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection | Q33844046 | ||
| Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. | Q33863064 | ||
| Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. | Q34112913 | ||
| Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways | Q34173731 | ||
| Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells | Q34274124 | ||
| Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. | Q34520814 | ||
| Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis. | Q34532538 | ||
| The role of cytokines in classical Hodgkin lymphoma | Q34661066 | ||
| Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity | Q36107713 | ||
| The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis | Q36371653 | ||
| Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells | Q38324140 | ||
| Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling | Q39741184 | ||
| Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells | Q39795545 | ||
| Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells | Q40553944 | ||
| Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation | Q40566781 | ||
| Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway | Q40623366 | ||
| Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52. | Q40628193 | ||
| Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma | Q40679662 | ||
| The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways | Q40696432 | ||
| Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells | Q40736248 | ||
| RelB cellular regulation and transcriptional activity are regulated by p100. | Q40771390 | ||
| Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. | Q40772885 | ||
| Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. | Q40972388 | ||
| GM-CSF-induced in vivo expansion of splenic dendritic cells and their strong costimulation activity | Q41180118 | ||
| The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma | Q44848855 | ||
| RelB/p50 Dimers Are Differentially Regulated by Tumor Necrosis Factor-α and Lymphotoxin-β Receptor Activation | Q57093168 | ||
| Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3 | Q73540287 | ||
| Of mice and men | Q80243690 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3976-3986 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts | |
| P478 | volume | 24 |
| Q36254865 | Activation of NF-kappaB by HTLV-I and implications for cell transformation |
| Q58698930 | Analysis of NF-κB Pathway Proteins in Pediatric Hodgkin Lymphoma: Correlations with EBV Status and Clinical Outcome—A Children's Oncology Group Study |
| Q40177590 | CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells |
| Q40026531 | CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells |
| Q40183372 | Efficient induction of HIV-1 replication in latently infected cells through contact with CD4+ T cells: involvement of NF-kappaB activation |
| Q36370847 | Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival |
| Q40383844 | Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD/SCID/gammac(null) mice |
| Q34707404 | Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma |
| Q38182355 | Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies |
| Q54147337 | NF-κB in Hematological Malignancies. |
| Q38178074 | NF-κB pathways in hematological malignancies |
| Q38988815 | NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms |
| Q37822660 | Non-canonical NF-κB signaling pathway |
| Q39468269 | Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells |
| Q34624443 | Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation |
| Q35125212 | TRAF2 recruitment via T61 in CD30 drives NFκB activation and enhances hESC survival and proliferation |
| Q50443743 | The NFKB Inducing Kinase Modulates Hematopoiesis During Stress |
| Q39350735 | The non-canonical NF-κB pathway in immunity and inflammation |
| Q40347662 | cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3. |
| Q36961217 | hESC adaptation, selection and stability |
Search more.